Osta Biotechnologies Inc. ("Osta"TSX-V:OBI) is a life sciences firm, currently focused on the development of Novel therapeutic products for Cancer and Alzheimer's disease. In addition, Osta has also developed a rich pipe line of novel diagnostic and therapeutic products for Alzheimer's
disease, Osteoporosis, Osteoarthritis and Xlinked Hypophosphatemic Rickets (XLH).

Osta's scientists are world-renowned clinicians, oncologists, bone biologists & neurologists with a proven track record of identifying, patenting and developing products and technologies for diseases affecting the aging population.

Osta's business strategy is to license out its diagnostic and therapeutic technologies at an early stage for clinical development, regulatory approval and marketing on a world-wide basis.